News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Andrea Menicucci

Articles by Andrea Menicucci

26 Prediction of Chemotherapy Benefit by MammaPrint® in Patients With HR+HER2- Early-Stage Breast Cancer From Real-World Evidence Studies

26 Prediction of Chemotherapy Benefit by MammaPrint® in Patients With HR+HER2- Early-Stage Breast Cancer From Real-World Evidence Studies

ByWilliam Audeh, MD,Harshini Ramaswamy,Andrea Menicucci

July 27th 2024

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

ByWilliam Audeh, MD,Nicole Chmielewski-Stivers,Harshini Ramaswamy,Andrea Menicucci

June 30th 2024

Latest Updated Articles

Trending on CancerNetwork

‘Seamlessly’ Integrating Bioimpedance Spectroscopy Into Clinical Workflows

FDA Approves Narsoplimab for HSCT-Associated Thrombotic Microangiopathy

Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer

Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML

Bioimpedance Spectroscopy is Allowing for Lymphedema Reduction in Breast Cancer